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ABSTRACT 
Adipocytes play an important role in insulin resistance through its endocrine 
functions such as production of tumor necrosis factor alpha (TNF-a). Adipocyte specific 
TNF-a inhibits insulin receptor protein tyrosin kinase activity causing the development 
of type2 diabetes (NIDDM). Nuc1eosides trigger a variety of regulatory effects in 
biological systems, such as inhibiting or stimulating protein synthesis. The present study 
was carried to screen seven synthetic nuc1eosides, for their effect on TNF-a release from 
adipocytes in vitro. Subcutaneous adipose tissue was dissected under sterile condition 
and plated in 24-well dishes in a humidified CO2-incubator in the presence or absence of 
various concentrations of the nucleosides for 48 hrs. There after media were collected 
and kept frozen until assayed for TNF- a. All nucleoside used had no effect on TNF-a 
release from adipocytes at low concentrations; however, higher nucleoside concentrations 
increased TNF -a release. 
The effects of polar extract of eight most commonly used medicinal plants in the 
treatment of diabetes were also investigated. Nigella sativa , Rhazya stricta and Salvia 
sclarea reduced adipocyte specific TNF-a release. Zygophyllum Simplex, Hammada 
elegans, Anastatica hierochuntica, Tephrosia apollinea and Teucrium stocksianum had 
no effect on TNF -a at low concentration. Further in vitro studies are required to 
investigate the effect of the fore mentioned polar extracts on the TNF -a induced insulin 
receptor down regulation and thus type2 diabetes treatment. 
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Chapter one: 
INTRODUCTION 
Diabetes mellitus is a principal cause of morbidity and mortality in human 
populations. (Steppan et al., 2001) This disease leads to complications including heart 
di ea e, troke, kidney failure, blindness and nerve damage. Several types of diabetes 
have been recognized in recent years (Stepp an et al., 2001) such as insulin dependent 
diabetes (type I, IDDM), non-insulin dependent diabetes (type II, NIDDM), and 
gestational diabetes. A minority of patients suffer from type I diabetes mellitus, which is 
cau ed by pancreatic �-cell failure and leads to an absolute loss of insulin. Type II 
diabetes mellitus is far more common, and is swiftly increasing in prevalence in 
industrialized societies (Steppan et aI., 2001). It is estimated that by the year 2020 there 
will be about 250 million people worldwide with NIDDM. This disease is the most 
common reason for blindness, renal failure and lower extremity amputation. Normally 
blood glucose homeostasis is regulated by appropriate insulin secretion and glucagons 
production. Insulin enhances glucose uptake by muscle and fat cells and suppresses 
hepatic glucose production (UN Das, 1999). 
Type I I  diabetes mellitus is characterized by target tissue resistance to insulin that 
cannot be overcome by �-cell hypersecretion (Stepp an et al., 2001). Failure of the target 
tissues to respond to insulin signals in NIDDM could be due to defects in insulin, 
Transform Growth Factor beta (TGF-�), Glucose transporter (GLUT-4), Tumor necrosis 
factor (TNF-a) or essential fatty acid metabolism induced signaling pathways (UN Das, 
1999). 
In the Middle East, recent socioeconomic improvement and changes in lifestyle 
have resulted in the emergence of diabetes mellitus as a major public health problem. 
However, reliable epidemiological data on type II (NIDDM) in most countries in the 
region remain scarce (Modebe, 1999). 25% of Bahraini adults, 20 years old or more 
attending primary health care centers in the country have diabetes mellitus; a further 
14.7% were found to have impaired glucose tolerance (Modebe, 1999). 
Both genetic and environmental factors contribute to the development of impaired 
glucose tolerance (IGT) and Type I I  diabetes. Obesity, physical inactivity and high fat 
diet have been found to be risk factors for impaired glucose tolerance (IGT) and Type I I  
diabetes (EI-Daly, 1998). 
OBJECTIVES 
The Objectives of thi tudy was to creen: 
1 - The polar extract of orne local UAE medicinal plants for their potential effect on 
TNF-a release from adipocytes in vi tro. 
2- Some new synthetic nucleosides for their ptent ia] effect on TNF-a release from 
Adipocytes in vi tro. 
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Table 1: Proposed WHO classification (1998) of Disorders of glycaemia (Modebe, 
1999). 
Type I Type II Other Specific types 







• Genetic defects of beta cell 
function 
• Genetic defects of insulin 
action 
• Autoimmune 
• May range from 
predominantly 
insulin resistance 
with relative insulin 
deficiency to a 
predominantly 
secretory defect with 
or without insulin 
resistance 





• Drug / chemically induced 
infections 
• Uncommon forms of 
immune-mediated 
diabetes 
• Other genetic syndromes 
sometimes associated with 
diabetes 




Factors : Life style 
Beta-cell defect: 
Impaired insulin secretion 
Defects in muscle, fat, liver: t Insulin resistance 
I Glucotoxicity I I Lipotoxicity I 
" � , / 
Type II diabetes 
Hyperglycemia 
Hyperlipidemia 
Fig. 1: Proposed aetiologic sequence in the pathogenesis of Type IT diabetes . (El-Daly, 
1998) 
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Diabete in the UAE 
FoIl wing the discovery of oil in the 1960s, the United Arab Emirates (UAE) 
d \' loped in many spheres: economically; educationally; medically and technologically. 
Th UAE society consists of national with rich cultural traditions, and large number of 
patriates from many parts of the world (Papworth & Fajou, 1998). 
The prevalence of NIDDM has been increasing during the last two decades and is 
approaching epidemic proportions in some developing countries. A World Health 
Organization (WHO) resolution on prevention and control of diabetes mellitus was 
unanimou ly adopted by the World Health Assembly in 1989. Populations embracing a 
We tern lifestyle who have previously lived under harsh circumstances are particularly 
usceptible to developing the disease. Countries of the Arabian peninsula provide a 
pertinent example of this problem. In this region, accelerated development has occurred 
over the past two decades as a result of the economic prosperity derived from the 
petroleum industry (Mpofu, 1994). 
Assessment of the impact of diabetes in countries such as Saudi Arabia, Kuwait, 
Bahrain and Oman reveals that NTDDM accounts for 90% of all diabetic diagnoses with 
up to 10% of all adult population being affected. The disease is twice as common in 
females than males. In that prevalence of diabetes is underestimated by about 50% 
using routine health statistics, it is easy to appreciate the staggering cost of the disease in 
this part of the world (Mpofu, 1994). Data obtained in the Gulf region reveals the 
incidence of NTDDM in the younger generation below 30 years of age is twice that in 
Europe (Mpofu, 1994). 
Obesity and related complications are a serious issue in the UAE. There is no 
hard data available for the UAE, although local studies and anecdotal evidence suggests 
that diabetes, especially NTDDM, is a major problem here. There is an urgent need to 
study the size of the problem and if, as is likely, diabetes is found to be in epidemic 
proportions then action will be required on a national scale (Townsend, 1996). 
The prevalence of NIDDM among UAE national adults is perceived as being raised 
when compared with western societies. Of the 495 adults screened, 123 were diabetic of 
which 21 were newly discovered by the screening exercise. The prevalence varied with 
the situation; 7% of those screened in the rural isolated area, 14% in the rural area and 
44% of the urban group were 25%. An additional 43% of those screened had impaired 
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glucose tolerance and were referred for further studies. The implications of these results 
ar di cussed with respect to screening and surveillance activities, and for the provision 
of h alth care services (Carson & Glasgow, 1995). 
Typell diabetes mellitus (NIDDM) is considered to be an important cause of 
disability in the United Arab Emirates (UAE). The evidence for this is largely anecdotal 
ba ed on the apparent high incidence of cases seen at the primary health centers and the 
high proportion of hospital beds occupied by patients with diabetes and diabetic 
complications (Townsend, 1996) of 433 patients approached a study of type II diabetes 
mellitus in AI-Ain 76 (17.5%) were known to have diabetes mellitus. This is 
con iderably more than expected as the usual consultation rate for non-pregnant 
diabetic patients in Al Ain is about 6% of all encounters (Townsend, 1996). 
The U.A.E. has a young population at the present time. It is expected that the 
number of people in those age groups in which diabetes is common will steadily 
increase over the next 30 years. In U.A.E. patients in age groups over 30 years, between 
5.7% and 11.2% of all encounters in the AI-Ain Health District result from diabetes. 
Diabetes is associated with the degree of urbanization and patient gender. For U.A.E. 
patients over age 30 at one clinic, 30.8% of diabetic males and 25% of diabetic females 
also had hypertension present (Garner et al., 1994). 
A national survey has found that 19.6 per cent of the UAE's population suffers 
from diabetes. The survey also revealed that 15.2 per cent of both nationals and 
expatriates have impaired glucose tolerance, increasing the risk of larger numbers of 
diabetics in the future. The diabetes survey, begun in 1998, was conducted by the 
Ministry of Health and the World Health Organization (WHO) (Papworth & Farjou, 
1998). 
The study was conducted on 6.609 men and women, including 2.363 nationals and 
4.246 expatriates. The number of women surveyed was 3.763. The results showed that 
19 per cent of women and 20.7 per cent of men are diabetic while 17.3 per cent of women 
and 12.4 percent of men have impaired glucose tolerance (Zabara, 2001). 
According to a study on changes in food consumption patterns in the Arab 
countries, published in the (international Journal of Food Science and Nutrition), the 
average per capita energy intake in the region has increased by 30 per cent in the past 
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thr e decades, the fat intake has increased by 45 per cent (Mathew, 2001) and therefore 
the Diabetes is increasing. 
The Diabetes is a particular threat because the number of people getting it in the 
U E i increasing every year. The main problem is that the number of diabetic patients 
i doubling yearly. The initial results of a major survey show diabetes affects people in 
the UAE at least 20 years younger than in the west. 
In non-Arab countries the age range for diabetic patients starts at 30_39, but in the 
UAE diabetes starts in early life, between the ages of 20 and 29 (Zabara, 2000). Diabetes 
patients show increased morbidity and mortality, primarily from cardiovascular and 
renal disorders. Furthermore, diabetes type II is linked to hypertension, which further 
accentuates the dismal prognosis of macrovascular disease. The prevalence of type II 
diabetes in UAE is among the highest in the world. This is also reflected in the high 
percentage of diabetics among inpatients and the marked increase in the occurrence of 
myocardial infarction, stroke and cardiac failure (Kumar et al., 2000). 
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OBE ITY A D DIABETES 
What i Obesity? 
Obe ity is an e cess of body fat frequently resulting in a significant impairment of 
h altho The excess fat accumulation is associated with increased fat cell size; in 
indi iduals with extreme obesity, fat cell numbers are also increased (Rizk & El­
Ghazaly, 1995). 
Obesity is a serious health problem in the UAE, declared a panel of experts at a 
recent symposium. In the past two decades, obesity figures have jumped among all age 
level of the population. 50% of men and 70% of women in the Middle East are 
overweight and obesity figures are higher than ever (Mathew, 2002). 
A cros -sectional study of 215 UAE University female students aged 18-30 years 
was undertaken to examine some factors associated with obesity among this group of 
females. It was found that 19 per cent were overweight and 9.8 per cent were obese. The 
proportion of obesity was the highest those 18 years old, with 31 per cent, compared 
with those 19 to 20 and above, at 23.8 per cent and 27.6 per cent respectively (Mathew, 
2002). 
Obesity is an independent risk factor for the development of atherosclerosis and 
cardiovascular disease and is associated with related metabolic disorders such as 
hypertriglyceridemia, hyperinsulinernia, and non-insulin-dependent diabetes 
(Lo kutoH, 2002). 
About 70% of UAE national women are obese, while 65% of national men suffer 
from the same problem. Diabetes and cardiovascular diseases are already a big issue 
(Mathew, 1998). The prevalence of reported diabetes is 2.9 times higher in overweight 
than non-overweight persons in the National Health and Nutretion Exmination Survay 
( HANES) data (Rizk & EI-Ghazaly, 1995). 
Obesity is associated with increased circulating levels of insulin and tumor necrosis 
factor alpha, and acute injection of either of these molecules into lean mice increase 
plasminogen activator inhibitor-l (PAl-I) mRNA 6-8-fold in the epididymal fat in cells 
that morphologically resembled adipocytes (Loskutoff, 2002). Since 70 to 80% of all type 
I I  diabetes patients are obese, (Hotamisligil, 1999). Many of pathological consequences 
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of obesity are thought to involve insulin resistance. These include hypertention, 
hyperlipidemia, and NIDDM (Hotamisligil et aI, 1993). 
Th influence of obesity on the development of type II diabetes is complex and is 
likely due to an interaction of genetic, nutritionat and metabolic factors. Much attention 
has been focused on the identification of molecular pathways that contribute to the 
development of obesity and type II diabetes. The cytokine tumor necrosis factor-a 
(TNF-a) is expressed primarily in adipocytes, where it is an important modulator of 
gene expression. In obese individuals, TNF-a expression is elevated and correlates 
strongly with hyperinsulinemia (Walston et al., 1999). 
The connection between increased adiposity and insulin resistance remains 
unknown. Although type II diabetes mellitus is strongly associated with insulin 
resistance in both human and rodent models of type II diabetes mellitus. (Stepp an et al., 
2001) A recent study suggested a new mechanistic link between insulin sensitivity and 
obesity (Kern et al., 1995). 
Insulin resistance 
Insulin resistance is defined as decreased ability of insulin to stimulate cellular 
glucose uptake (Brindley et aI, 1998). 
In the most general sense, insulin resistance (or any hormone resistant state) may 
be said to exist whenever normal concentrations of hormone produce a less than normal 
biologic response. Insulin resistance should be regarded as a /I generic" term. One may 
speak of insulin resistance in terms of the entire organism, a single tissue, a single cell, 
or even a single metabolic pathway. This definition differs slightly, but significantly, 
from the most frequently quoted definition of insulin resistance, namely that proposed 
by Berson and Yalow several years ago. They defined insulin resistance as "a state in 
which greater than normal amounts of insulin are required to elicit a quantitatively 
normal response' While for most purposes their definition is adequate, not that there 
are two important features that limit its usefulness: 
The state of resistance is defined by a response to a greater than normal amount of 
insulin. The definition implies that a I quantitatively normal response' can ultimately be 
achieved (Kahn, 1978). 
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It i a final consequence of the type II diabetes mellitus. This involves activation of 
th insulin receptor (IR) by phosphorylation of tyrosine residues, which then causes the 
tyro ine ph sphorylation of insulin receptor substrate-l (IR-l). Activated IRS-lthen 
binds phosphatidylinositol 3-kinase (PI3-kinase), which itself becomes activated and 
timulates the movement of glucose transporters (mainly Glut 4) to the cell surface. The 
increa e in Glut 4 at the plasma membrane is then responsible for insulin-dependent 
gluco e uptake. Insulin resistance result from a decreased efficiency in stimulating this 
ca cade. It can occur in sepsis, advanced cancer and trauma partly as a result of TNF-a 
action (Brindley et aI, 1998). 
Adipose t issue 
Adipose tissue is considered as an energy storage tissue. However recently is 
considered an endocrine organ that primarily functions to manage energy homeostasis. 
Adipose tissue is a normal constituent of the human body that serves the important 
function of storing energy as fat for mobilization in response to metabolic demands 
(Rizk & El-Ghazaly, 1995). 
The study of adipocyte biology is important not only to understand metabolic 
diseases (including obesity, diabetes, dyslipidemia, and atherosclerosis), but to develop 
pharmacological agents to treat such maladies. Adipose tissue is critical for maintaining 
energy balance, because it serves both as a storage depot and an endocrine organ. It is 
actively involved in sensing the nutritional state of the organism through several 
different signaling pathways. It responds by altering the expression of genetic 
pathways to mobilize or store energy and activating signals to other tissues to regulate 
energy balance (Halvorsen et al., 2001). 
Adipocytes also secrete a variety of polypeptides, such as leptin, tumour necrosis 
factor a (TNF-a), a dipsin and adipocyte compliment related protein-30 (Acrp 30) / adipo 
Q, that may affect insulin action in other tissues (Stepp an et al., 2001). 
Many studies show that TNF- a release from adipose tissue is responsive to LPS 
(cell -wall component of Gram-negative bacteria) but not to insulin. LPS also 
stimulated TNF-a release from isolated adipocytes. The finding that LPS stimulates 
TNF-a production from human adipocytes suggests a role for adipocyte TNF in host 
defence (Sewter et al., 1999). 
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Tumor ecro is Factor-alpha (TNF- a.) 
Tumor necrosis factor alpha (TNF- a.) IS a cytokine produced primarily by 
mon cyte and macrophages (Elliott et al., 1994). It is found in synovial cells and 
macrophage in the tissues. It shares many properties with another cytokine interleukin 
1. It is not unique to RA, but occurs in many inflammatory diseases, and also as a 
respon e to endotoxins from bacteria for example (Elliott et al., 1994). 
TNF has multiple actions in adipose tissue, which include a decrease in the activity 
of liopoprotein lipase (LPL), a decrease in expression of the glucose transporter Glut 4, 
and an increase in hormone-sensitive lipase (Lofgren et al., 2000). 
Tumor Necrosis Factor and Obesity 
Tumor necrosis factor- a. (TNF-a) is a pleiotropic factor that exert variety of effects 
on growth promotion, angiogenesis and cytotoxicity. Synthesized mainly by 
macro phages as a 51 kDa trimer TNF-a recognized by two different receptors, TNFR1 
and TNFR2. 
TNF-a acts in an autocrine or paracrine way or in endocrine fashion when released 
in high concentrations (Kern et al., 1995). Soluble forms of the two receptors also found 
in healthy individuals. TNFR2 over expressed in adipose tissue of obese humans (with a 
trong correlation with Body Mass Index (BMI), hyperinsulianemia and TNF mRNA 
levels in adipose tissue). Suggest TNFR2 may play a role in obesity by modulating the 
actions of TNF (Kern et al., 1995). 
In adipose tissue, TNF-a inhibits lipoprotein lipase synthesis as well as the 
synthesis of acetyl-CoA carboxylase, fatty acid synthase, fatty acid-binding protein and 
glycerol phosphate dehydrogenase, all these enzymes being involved in fat synthesis. 
Stimulates triacylglycerol degradation in the adipocyte activating the hormone-sensitive 
lipase. Stimulates liver lipogenesis and hepatic very low density lipoprotine (VLDL) 
production, TNF-a causes a severe hypertriglyceridaemia (Kern et al., 1995). 
The production of TNF-o. by adipose tissue could be a local regulator of fat cell 
size, and the overproduction of TNF-o. in adipocytes of obese animals could represent a 
form of IJadipostat" (Kern P.A. et al., 1995). It is interesting to note that TNF-a is also 
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produced in human muscle and that the muscle production is increased in obesity 
(L fgren et al., 2000). 
The principal mechani m of TNF-a resistance in obesity can either come from the 
increa ed removal of the transmembrane-bound forms of cytokine and its receptors, or 
from an increa ed e pression of anti-apoptotic proteins in adipocytes induced by TNFR-
2 or from both of these mechanisms (Cseh et al., 2000). 
It also timulates T-cell-mediated immunity to tumor cells and has a direct 
cytotoxic effect on tumor cells, especially when combined with other cytokines (Auwerx, 
1998). 
The TNF cau es: 




Increased tissue damage by interlukin I ( IL 1) 
Induction of collagenases by fibroblasts and chondrocytes. 
Has a role in modulating Hella cells (HLA) class 2 expression, as well as the 
adhesion molecules (Elliott MJ. et al., 1994). 
Tumor necrosis factor (TNF-a) has been proposed as a link between adiposity and 
the development of insulin resistance, because: 
The majorities of type II diabetic patients are obese and show increased TNF-a 
ex pres ion in fat cells. Obese mice lacking TNF-a function have shown protection for 
developing insulin resistance. 
Direct exposure of isolated cells to TNF-a inhibits insulin signaling and induces a 
state of insulin resistance by a mechanism involving Serphosphorylation of insulin 
receptor substrate (IRS-I) that converts IRS-l into an inhibitor of insulin receptor 
tyrosine kinase activity in vitro (Teruel et al., 2001). 
The receptors for the Turner Necrosis Factor alpha (TNF-a) are on several 
mononuclear cells, in the synovial membrane, as well as the peripheral blood and 
synovial fluid. There are also soluble receptors-receptors that are free in solution. These 
are shed in Rheumatoid Arthritis (RA), systemic lupus erythematosus (SLE), Systemic 
Sclerosis, mixed connective tissue disease (MCTD), and to a certain degree 
Osteoarthritis (OA), although the latters is less than the levels in RA. 
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Tumor necrosis factor alpha (TNF-a) is a critical inflammatory mediator in 
rheumatoid arthritis, and may therefore be a useful target for specific immunotherapy 
(Elliott et al ., 1994). 
Tumor necrosis factor alpha (TNF-a) have important metabolic effects, including 
direct effects on adipocyte metabolism. TNF-a acts in vitro on marine adipocytes to 
uppress e pre sion of most adipose- specific genes, including the enzymes involved in 
lip ogene is. TNF-a administration causes an increase in serum triglycerides and very 
low-den ity lipoproteins in rats and humans (Hotamisligil et aI, 1993). 
According to the results of a study of TNF receptors on differentiation and glucose 
metabolism in human adipocytes in primary culture, TNF-a inhibits fat cell 
differentiation and may also mediate insulin resistance in adipocytes. Both TNF 
receptors are expressed in adipose tissue, but it is unknown how both receptors are 
involved in these biological functions (Hube & Hauner, 2000). 
The cytokine (TNF-a) is expressed in the adipose tissue of rats and mice and is 
e pressed at higher level in the adipose tissue from genetically obese rodents. In 
addition, this overexpression of (TNF-a) is in part responsible for insulin resistance in 
rodent obesity. After infusion of anti-TNF binding protein, insulin sensitivity improves, 
owing to improved insulin receptor tyrosine kinase activity (Kern et al., 1995). 
Interestingly (TNF-a) inhibits insulin-stimulated glucose uptake by different 
mechanisms. In rat Fao hepatoma cells, components of the insulin signaling pathway 
were reported to be down regulated within 1 h of TNF exposure. Comparable results 
were described after short-term TNF treatment of human adipocytes and also after 
chronic 5-day incubation of 3T3 adipocytes with TNF. In addition, long-term TNF 
treatment down-regulates mRNA expression of the insulin-responsive glucose 
transporter-4 (Glut 4). 
Based upon these findings, TNF appears to inhibit insulin stimulated glucose 
transport by suppressing both the production and translocation of the Glut 4 protein 
(Hube & Hauner, 2000). 
TNF-a treatment of human adipocytes induces a rapid and marked (60-70%) 
inhibition of insulin signaling at the level of pr3-kinase. And this study show that 
insulin signaling in human adipocytes is highly sensitive toward TNF-a and acutely 
modified by the cytokine involving the p80 TNFR2. These data strongly support the 
1 2  
concept that TNF-a i a key mediator of obesity-associated insulin resistance and e tend 
it to human adipose tissue (Liu et al., 1998). TNF-a production in rat kupffer cells was 
high r in ethanol-fed rats in response to stimulation with lipopolysaccharide or latex 
b ads (Aldren & Nagy, 1999). 
orne compounds effect the secretion of TNF from adipose tissue and one of these 
comp unds Lipopolysachride (LPS) and Thiazolidinediones (TZDs). 
Lipopolysachride (LPS)-induced tumor necrosis factor and interleukin-6 production 
from rat Kupffer cell (Lin et al., 1997). Lipopolysacharide (LPS) stimulate TNF-a protein 
production in monocytes and macrophages, result in a fivefold stimulation of TNF-a 
release from adipose tissue (Sewter et al., 1999). 
Investigation the effect of TZDs (Thiazolidinediones) on the regulation of 
adiponectin gene expression in 3T3-L1 adipocytes, suggest that the TZDs derivatives 
(Troglitazone) TGZ, (Pioglitazone) PGZ and (Rosiglitazone) RGZ, increased the plasma 
diponectin concentrations in humans and rodents through the activation of its promoter. 
The structure of RGZ 
Adiponectin inhibits the expression of adhesion molecules and prevents the 
attachment of monocytes in TNF-a stimulated human aortic endothelial cells. This 
protein also dramatically suppresses the secretion of TNF-a from macrophages and 
foam cell formation (Maeda et al., 2001).Another study on the effect of 
(Thiazolidinediones) Troglitazone(TRG) in TNF-a support the efficacy of using (TRG) in 
human type2 diabetes (Solomon et al., 2001). Rosiglitazone (RGZ) was used to inhibit 
the adiposite specific releas of TNF-a (Stepp an et al., 2001). 
Investigators found that TNF (alpha) expression in transduced cells was 
undetectable when the culture medium contained as little as 0.1 I-lg/ml of Tc. 
Additionally, they determined that a percentage of the clonogenic cells from human 
peripheral blood stem cell concentrates could be transduced by TNF-a (Marble, 1997). 
TNF-a bcauses pronounced alterations in glucose metabolism that are similar to 
those observed in patients with chronic inflammatory diseases. These changes include 
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an enhanced utilization of glucose mainly by muscle but also by other tissues, and an 
mcreased glucose production (Hauner et al., 1995). 
A recently published report suggest that: 
TNF-a is a peptide constitutively expressed and secreted by adipose tissue, which 
increa es in the obese. This increased expression of TNF-a is reflected in supranormal 
T F-a concentrations in serum and may contribute to insulin resistance. 
After weight loss, TNF-a expression and secretion fall, in association with a fall in 
erum TNF-a Oconcentration and a decrease in insulin secretion after glucose challenge, 
reflecting a fall in insulin resistance. 
Because TNF-a, constitutively secreted by adipose tissue, may arnve through 
circulation at distal sites pose tissue (like the skeletal muscle, the liver, and the heart) to 
induce an effect antagonistic to insulin, through the inhibition of the insulin receptor 
tyro ine kinase, TNF- a may well be qualified to be termed a hormone, whose 
constitutive source, the adipose organ, may thus be termed an endocrine organ 
(Dandona et al., 1998). 
Loss of both TNF receptors and leptin (p55-/ -p75-/ -ob / ob) resulted in a more 
dramatic protection from obesity-induced insulin resistance and diet-induced obese 
mice lacking both receptors exhibited hyperinsulinemia in a moderately fasted state, 
and insulin levels remained elevated upon severe fasting. This suggests that TNF 
receptors may be required for normal glucose homeostasis (Schreyer et al., 1998). 
TNF and Glut 4 
One of the first steps in glucose utilization is the transport of glucose across the cell 
membrane facilitated by GLUT (glucose transporter protein). There are about 6 GLUT 
receptors that have been described. Of all, GLUT-4 is expressed mainly in insulin­
responsive tissues, muscle and adipose tissue. Among the two, skeletal muscle takes up 
about 80% of postprandial glucose (UN Das, 1999). 
Normally, once insulin comes in contact with the cell, GLUT-4 gets translocated to 
the plasma membrane from the cytoplasm to facilitate transport of glucose into the cell. 
Both animal and human studies have suggested that there is a decrease in insulin­
mediated glucose transport in diabetes mellitus. Since GLUT-4 may be responsible for 
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the decrea e in glucose uptake by adipose tissue and muscle of diabetic patient (UN 
Da , 1 999) .  
everal studies on glucose transport systems as potential sites for such a 
po treceptor defect have demonstrated that both the quantity and function of Glut- 4, 
e pecially in muscle, the major site of glucose disposal (Hotamisligil et al ., 1 993) .  
The mechanistic link between obesity and insulin resistance is not understood. 
Much attention has been focused on the role of free fatty acids as potential mediators of 
in ulin resistance. TNF-a is a mediator of insulin resistance. Additional experiments 
with other reagents against TNF-a and in other animal models will be necessary to 
determine the extent of this cytokine's role in obesity-linked insulin resistance 
(Hotamisligil et aI, 1993). 
Incorporation of glucose into lipids is decreased after short-term treatment of 3T3-
Ll cells with supernatants of activated macrophages. Treatment of L6 myotubes and 
3T3-L1 adipocytes with recombinant TNF-a causes down-regulation of Glut 4 
expres ion (Hotamisligil et al., 1993). 
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< I . 2 .  Model for the role of TNF-a in obe ity-l inked insul in re istance.Thi model ,  
ugge t s  that TNF-a expre ion in fat t i  ue  is induced in  obesity and 
cau e" in  u l in  re i tance by interfering with in u l in  receptor tyrosine kinase activity in fat and 
mu c le ti ue . Effect on l iver are not c lear at this time. The act ion of TNF-a on fat and 
mu de appear to be through autocrine/paracrine route ; however, it is not clear whether the e 
act ion are direct or indirect . An endocrine effect is a1 0 po sible through the acces of 
ecoundary mediator to cystemic circulation (vascular bed). Other abnormal ities that might 
potential ly be induced by TNF-a uch as regu lation of mRNA levels of GLUT4 in fat 
(de rea e) and TNFR-2 in  fat and muscle (increa e) and functional abnormal ities of 
pan reat ic B-ce l l ,  are al 0 shown (Hotamisl igi l  & Spiegelman , 1 994) 





OTH ER EFFECTORS 
FFA ? 
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F-a A D I ULI RESISTANCE 
tudie in rodents support a role for TNF-a as a mediator of IR, a recently 
publi hed report demonstrated that targeted disruption of the TNF-a gene in mice 
r ulted in reduced body adiposity and triglyceride levels in nonobese animals, but the 
ab ence of TNF-a was 'not sufficient to substantially protect against insulin resistance'. 
The e apparently contradictory findings have led to controversy about the role of TNF-a 
in the IR syndrome. A study in Native Canadian population supports a significant 
contribution of TNF a to the pathogenesis of obesity-related IR and glucose intolerance 
in thi population (Zinman et al., 1999) .  
In  other study of  the effects of pregnancy and exercise on concentrations of the 
metabolic markers tumor necrosis factor alpha and leptin show that regular weight­
bearing e ercise during pregnancy suppresses the pregnancy-associated changes 
normally seen in both tumor necrosis factor alpha and leptin. The decrease in leptin 
reflects decreased fat accretion, and the changes in tumor necrosis factor alpha may 
reflect a change in insulin resistance (Clapp & Kiess, 2000) .  
Recent studies in 3T3 Ll adipocytes suggest that TNF-a induced insulin resistance 
could be due to a transcriptional suppression of the GLUT-4 gene resulting in a total 
depletion of insulin-sensitive glucose transporters. A direct role of TNF-a in the 
de elopment of insulin resistance has been implicated by a recent study in genetically 
obese rodents that indicates an association between an increased expression of TNF-a in 
adipose cells and insulin resistance (Hauner et al., 1995). TNF- a could be affecting 
insulin-stimulated glucose uptake in obese rodents by lowering glucose use by fat, 
muscle, or both (Hotarnisligil et aI, 1993) .  
Two mechanisms have been suggested by which TNF-a may induce insulin 
resistance: 
1 .  An increase in insulin-regulated protein expression such as lipoprotein lipase 
and Glut 4 by a serine phosphorylated IRS-l (insulin receptor substrate-I ). 
2 .  Down regulation of insulin receptor tyrosine kinase activity. 
The studies suggest that TNF-a limits adipose tissue expansIOn initially by 
inhibiting differentiation of preadipocytes. Consistent with the observations that 
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mic bolu injections of TNF-a act as a short term anorexic and that TNF-a 
in) cbon up-regulate leptin mRNA and protein (Hamilton, 1998). 
The link between obesity and peripheral insulin resistance is not fully understood, 
although recent studies suggest that tumor necrosis factor TNF-a may play an 
lInportant role (Lofgren et al., 2000) 
T F-a ecretion is markedly increased m vitro from adipose tissue of obese 
ubjects (Lofgren et al., 2000). 
The relationship between circulating TNF-a and insulin sensitivity is unclear. 
orne tudies show positive correlations with BM! (Body Mass Index) and insulin 
ensitivity and show negative correlations with weight loss or other treatments. TNF-a 
ecretion showed no relation to basal lipogenesis but showed a strong relation to 
rna imum insulin-stimulated lipogenesis (Lofgren et al., 2000). 
TNF-a may be an important local factor that influences the ability of insulin to 
timulate glucose transport in human fat cells (Lofgren et al., 2000). 
The biochemical basis of insulin resistance in type II diabetes has been the subject 
of many studies. Earlier studies have indicated that quantitative regulation of the 
in ulin sensitive glucose transporters (Glut 4) and insulin receptors themselves may 
contribute to this disorder. 
A reduction in tyrosine phosphorylation of both the insulin receptor (IR) and the 
insulin receptor substrate-1 (IRS-1) has been noted in both animal and human type II 
diabetes(Hotamisligil G.s., 1999). Some studies suggest that TNF-a may induce hepatic 
insulin resistance by preventing Focal adhesion kinase (FAK) phosphorylation in 
response to insulin treatment (Cheung et al., 2000). 
Administration of TNF-a to experimental animals induces insulin resistance and in 
vivo inhibition of TNF-a by blockade of TNF-a bioactivity, and genetic knockout of the 
T F receptor and / or the TNF-a ligand has been shown in most but not all studies to 
improve insulin sensitivity and glucose metabolism (Cheung et al., 2000). 
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Under normal conditions, insulin activates FAK in the liver by promoting its tyrosine 
pho phorylation. However, the increased TNF-a levels in obesity trigger the expression 
of LAR in the liver via an undetermined mechanism, the increased LAR abundance may 
simultaneously dephosphorylate FAK, thus antagonizing signal transduction via the IR 
(Cheung et al., 2000) .  
(T F-a) is an important mediator of the glucose metabolic response in cancer and 
infectious di ease, available evidence suggests that (TNF-a), probably in combination 
with other cytokines, has a direct effect on glucose disposal. 
(TNF-a) increased glucose uptake in tissue that are either completely insulin 
insensitive or only minimally insulin sensitive. 
According to the results of the same study (TNF-a) produces both hepatic and 
peripheral insulin resistance. (TNF-a) (alone or in combination with other cytokines) 
could reduce the number or activity of the Glut 4 (insulin-sensitive) isoform (Lang et al., 
1992). 
According to the result of FRANK H. and HANS H. study, TNF is not only acting 
as an antiadipogenic factor for fat cells and their precursors, but also seems to be able to 
promote fat cell differentiation under certain conditions via a specific P80-TNFR 
mediated effect. This pattern of opposite signaling includes the regulation of Glut 4 
expreSSIOn; where P80-TNFR- mediated signals do not substantially affect Glut 4 
expreSSIon. Both (TNF-a) receptors appear to mediate a suppression of insulin 
resistance (Hube & Hauner, 2000).  
TNF-a suppresses LPL mRNA potently stimulates lipolysis and was found to 
abolish the insulin effect on glucose transport. The combination of these effects may be 
responsible for the delipidation of cultured human fat cells observed under chronic 
exposure to high concentrations of TNF-a and may also contribute to the development 
of insulin resistance in states of increased TNF-a production (Hauner et al., 1995) .  
Leptin and Insulin resistance 
Leptin (from the Greek leptos=thin) was identified recently. It has attracted huge 
attention both scientifically, and in the media, where this protein has been portrayed as 
the way to a cure for obesity. Indeed, leptin was first described as an adipocyte-derived 
signaling factor, which induced a complex response including control of bodyweight 
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and en rgy e penditure. Leptin is a fat derived hormone that regulates food intake and 
energy metabolism (Shimomura et al., 1999). 
Human obesity is a complex disorder, with many factors playing a part; the 
pathophysiology of leptin is not as simple as it seems to be in rodent models of obesity 
( uw r , 1 998). Leptin seems in addition to its role in metabolic control to have 
important roles in reproduction and neuroendocrine signaling. Some studies results 
upport the idea that leptin modulates insulin sensitivity and glucose disposal 
independently of its effect on food intake, and that leptin deficiency accounts for the 
insulin resistance found in CGL (congenital generalized lipodystrophy) (Shimomura et 
al., 1999). 
Tumor necrosis factor (TNF-a) and the obese gene product, leptin, have been 
suggested to act as "adipostats" in the regulation of adipose tissue homeostasis. 
Investigations with TNF-a receptor 1 knock-out mice suggest that TNF-a acts both 
through paracrine actions and through the up_regulation of obese leptin expression to 
limit expansion of adipose tissue under normal conditions. Under conditions of energy 
overload and / or leptin resistance, TNF-a , rather than limiting adipose tissue 
e pansion, increases fat cell number causing a reduction in average fat cell size and a 
consequential resetting of the organisms "set-point" (Hamilton, 1998). 
Another study was undertaken to examine the regulation of leptin production from 
human adipocytes by tumor necrosis factor-a (TNF-a), the data of this study suggest 
that the direct paracrine effect of adipose-derived TNF-a is inhibition of leptin 
production (Fawcett et al., 2000) . 
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1\ 1  D J  J A L  PLA T 
From ancient t ime to the beginn ing of the modern era, people of al l c las e had a 
comprehen i e knowledge about p lants and their u age to human beings. Plants are u ed a food 
and a ea oning as well a in the medicine field wi thout having investigated the material s 
compo ing them (Gabriel ,  1 979). Herbs have been an integral part of our hi tory since the dawn 
of time, and throughout the age they have been highly prized and cultivated for their properties. 
Th World Health Organization e t imates that 85% of the world 's  population rel ies most heavi ly 
on tradi tional , herbal medic ine, making it several times more widespread than conventional 
we tem medicine (Punnose, 1 999). 
ow a day mo t research I S  done on many plants to see their potential effect m the 
treatment of many di eases. 
The UAE de ert ha many p lants that are used in  folk medicine, 
1)  ZygophyllulIl spp. or Zygphyllum simplex L. 
Local Name: fR 
Smal l ,  succulent annual, branching from base and forming prostrate mat, sometimes 
circular or oval in  out l ine with branches to 20 em but usual ly shorter branches sometimes red .  
Young plant w ith aspect of squat inverted pyramids on  short stem. Leaves fleshy, cyl indrical , 
u ual ly grouped in  3-5 pairs of decreasing size at branchlet tips, often quite yel lowish, very 
glo y. Flowers axi l l ary, sol i tary or paired with t iny open yel low petals. Flowering period : Mar.­
Jun. ,  occasional ly autumn;  p lan t  may appear yel low-spangled al l  over. Fruit pod-l ike, 5-angled 
and oft. 
Habitat and d istribution: 
Common on l imestone along Arabian Gulf l ittoral ,  in  central desert area and along east 
coa t as wel l  as foothi l l s. Rare in deep sand; rapidly colonises gypseous soi l s  and local ly 
dominant annual west of Jebel Dhanna (Thomas, 2000). 
Constituents :  The plant contain flavonoids (kaempferol 3-glucoside and quercetin 3 ,7-
digluco ide), isorhamnet in ,  isorhamnetin 3-0-g1ucoside, kaempferol 3-0-rut inoside and 6 '  -(2-E­
butenyl) isorhamnet in 3 -0-glucoside) ,  sitosterol glucoside and quinovic acid 3-a -L-rhamnoside. 
U es : The leaves are used as an antibiotic and l axative. Infusion of leaves or the seeds is appl ied 
to the eyes in ophthalmia. The seeds are anthe lmintic .  
2 1  
Effect : The plant pos e se antibacterial act ivity again t Staphylococclls aureus, Bacilllls 
sllblillS, Escherichia coli and Pseudomonas aeruginosav (Kotb, 1 985) .  
Figure 3 .  Zygophyllllm spp. Or Zygphylllln7 simplex L .  
a. Whole plant 
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2) Hammada elegans (Bge.) Botsch 
Local arne : Rirnth �yl 
Large perennial , much-branched, to 1 . 5m.  Branches jointed, bluish-green and fleshy when 
young gradual ly hardening d i rty grey. Leaves oppo ite but rudimentary with woolly ax i l , i n  
older plant often enlarged by gall -producing insect and turning pink or reddish. Flowers 
Il1 l 11U le ,  el low, th ickly dotted along outer twig . Flowering period: Sep. -Dec . Flowering and 
fruit ing imul taneou . Recognizable by fruit perianths, which c lothe plant with conspicuous 
pink, brown or whi te enlarged papery wings (Thomas, 2000). 
Habitat and distribution : 
Common and in places dominant in  stable sand especial ly in central areas and on al luvial 
plain . Form huge mounds northeast of Abu Dhabi town,  where perianth wings are most ly  
white; on  Dhaid and Madam plains  they are mainly pink.  Wings sought after by  ants; shrub 
brow ed by camel s  (Thomas, 2000). 
Constituents : The p lant contains alkaloids, coumarins, saponins, sterols, cardiac glycosides ,  
flu onoid , tannins and volati le o i l .  
Effect : The p lant posse ses ant imicrobial activ i ty again t Staphylococcus aureus ( Kotb, 1 985) .  
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Figure 4 .  Hammada elegans (Bge) Botsch. 
a. Whole plant 
b .Flower 
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3 A na tatica hierochuntica L. 
Local name:  �...jA US 
Dwarf annual , overal l  grey with covering of furry hairs branching out and upward from 
ba e to 1 0  cm. Leave mal l ,  hovel- haped to 1 . 5 em at ends of branchlet , deciduous. Flower 
In clu ter In branch fork , often dirty with blown and and du t, urrounded and dominated by 
leave . Petal minute, whi te .  Flowering period: Feb.-May. After flowering all branches harden 
and bend inward to enelo e fruit  in tight basket- l ike cover; this unfurls in next seasonal rain and 
bro n eed ca t around (Thomas, 2000). 
Habitat and distribution : 
Common on gravels and compact alluvium at ba e of mountains. Known both as 'Rose of 
Jeri ho' and 'Hand of Miriam'.  In  early spring parent plants surrounded by vast number of 
eedl ing , but only a few survive to maturity (Thomas, 2000). 
Constituents :  The aerial and underground parts contain flavonoids ( luteol in 7-glucoside 
i 00 itex in  kaempferol 7-glucoside, kaempferol 3-rhammoglucoside, quercetin and rutin) and 
gluco i nolate (glucoiberin and glucoheirol in) .  The si l iculae contain glucoiberin ,  luteol in ,  
luteol in 7-g1uco ide, hydrocarbons and sterols. 
U es : Infusion of the dry plant is  prescribed in  folk medicine to ease uterine haemorrhage, to 
fac i l itate the expul ion of a dead foetus and by women as a charm in chi ld birth parturi facient and 
emmenagogue ( Kotb, 1 985) .  
Effects : The chloroform extract of  the plant possesses anti - inflammatory act ivity; giving 60% 
Inhibi t ion of 1 2-deoxyphorbol phenyl acetate induced erythema of mouse ear . The 
gluco inolate of the plan t  have a hypotensive effect on rabbit blood pressure. Extracts of the 
plant pos e s moderate antibiotic activity and ant imicrobial activity against Staphylococcus 
aureus. In India, the plan t  has been reported as an abortifaciant and to possess contraceptive 
properties ( Kotb, 1 985) .  
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Figure 5. Anastatica hierochuntica L. 
a. Whole plant 
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4) Tephro ia apollinea (Del.)Dc. 
Local name: D HAFRA o �\ 
Gray low hrub, den ely leafy, erect, up to 70 cm. In height. Stems, woody below, much 
branched , tout, and hairy. Leave gray, hairy al ternate, odd-pinnate or compound with 3-5 pairs 
of hort petiolate, oblong to obovate or spathulate, mucronate; leaflets 2-4 cm. Long, each leaflets 
with con picuou mjdrib and paral lel veins, Stipule more or less spiny. Inflore cence racemes of 
long terminal 3-6 flowers. Flower about 1 cm. Long , purple or red .  Calyx 5-toothed. Corol la  
papi l ionate, twice as long a calyx .  Fruit a pod, 2-4 cm.  Long, flattened, falcate, dark brown with 
many e l l iptical eeds . Flowering period: January - June (Thomas, 2000). 
Habitat and d istribution : 
Broad leaf, dicot , propagates by seeds . Very common desert plant ,  in  fal low fields and road 
ide in  AI-Ain , Hatta, Masafi ,  Fujeirah, Khor Fakkan and Ras AI-Khaimah (Western , 1 989). 
e : Bronchi t is ,  cough, earache, nasal congestion , pain from bone fractures,  swel l ing, wollen 
joint and wounds (Ghazanfar 1 994). 
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Figure 6. Tephrosia apollinea (DeL.) Dc. 
a. Whole  plant 
b Flower 
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5) Rhazya tricta Decne 
Local name: J,A�\ 
hrub with mooth central tern and den e emierect branches to 1 m but general ly horter, 
50-70 cm. Branche covered with erect leaves to 1 2  em on hort stalks, with prominent midrib. 
Flower with white petal to 2 cm, Flowering period : Feb.-Jun. Frui ts cyl indrical in erect groups 
of paiL ,  green maturing chocolate brown, to 8 cm. (Thomas, 2000). 
Habitat and d istribution : 
er common on al luvial p lain around Al Ain and on gravels  east and we t of Hajjar 
M untain ; ometimes in extensive clumps in wide lower wadis. e .g .  Wadi Bih in Ras a l  
Khalmah. Wide pread south of Al Ain towards Liwa on gravels, where is i t  local ly dominan 
(Thoma 2000). 
Constituents :  The leaves and roots contain 4 indole alkaloids 3 of which, vallesiachotamine, 
e\ arine and tetrahydrosecamine, show cytotoxic activi ty .  Nige l l icine, an alkaloid has been 
i olated from the eeds(Ghazanfar, 1 994). 
Uses : Anthelmint ic ,  febrifuge, l actagogue, Vermicide. Abdominal pain ,  bad breath, chest pain ,  
colic, conjunctiv i tis, constipation, diabetes, fever, lactation , skin rash, sore throat, worms 
(Ghazanfar, 1 994) and urinary tract problems (Hassan , 2002) .  
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Figu re 7. Rhazya stricta Decne. 
a. Whole plant 
b .Flower 
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6)  Teucrium tocksian um Boi . Sub p .  Stocksianum 
Local name:  o �1 
Den e, compact perennial hemispherical in out l ine to 30 em high and acros . Root tock 
\: oody, with many erect white furry stems. Lower half of inside branches u ual ly leafless; lea es 
to 1 e m ,  in pair with errated margin and distinct midribs; occasional ly group of smal ler leaves 
on ide talk , ometime later giving plant  a characteri t ic dotted green and brown appearance ; 
upper l ip  ab ent .  Flowering period : February to June (Thoma , 2000). 
Habitat and d istribut ion:  
Fairly wide pread at  upper mountain elevations in  smal l groups; also recorded in desert 
plantation at Shwayb (Thomas, 2000). 
Con tituents :  Ditepenoid : picropol in ,  6-acetyl picropol in ,  isopicropol i n ,  1 9-acetylgna teucrins 
P l ,  P2 and P3, montanin ,  teupl ins I -V. Iridoids, flavonoids, hedraursolic acid, a-and �-amyrins, 
and volat i le oil (Batanouny, 1 999) . 
U e : Col ic, diabetes, fever, stomach pain (Ghazanfar, 1 994) . 
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7 igeUa ativa 
Local name: p /Jp/ �/ 
I igelfa ha been u ed ince antiquity by A ian herbali t and pharmaci t and wa u ed for 
ul inary purpo e by the Roman . The eeds are known to repel certain insect and can be used 
l ike moth bal l . The name nigella derive from the Latin nigellus, or niger, mean ing black. 
igella i u ed in India and the Middle Ea t as a pice and condiment and occasional ly in Europe 
as b th a pepper ub titute and a spice (Kareem, 1 995) .  
ther Nam 
Black Caraway, B l ack Cumin,  Damascena, Devi l  in  the bush, Fennel flower, Melanthion, 
utmeg Flower, Roman Coriander, Wi ld Onion Seed ( Kareem, 1 995) .  
Plant Description and Cultivation 
An herbaceous annual of  the buttercup fami ly, about 60 em (2ft) high. The gray-green 
leaye are wi py and threadl ike .  Flowers are hav ing five petals bout 2 . 5  em wide ( l in) ,  white 
\ i th blue vein  and appearing between June and September. They yield a seed capsule with five 
compartment each  topped by a spike. The compartments open when dried to disperse the seeds. 
igella i native to we tern Asia where it grows both wild and cult ivated. India, Egypt and the 
1iddle Ea t also cul t ivate it ( Kareem, 1 995) .  
Attributed Medicinal Properties : 
Nigel/a is used in Indian medicine as a carminat ive and stimulant. It is also used against 
indige tion and bowel complaints. In India i t  is  used to induce post-natal uterine contraction 
promote l actation. The seed yields a volat i le  o i l  containing melanthin nigi l l i ne ,  damascene and 
tannin .  Studies showed that NS had difininte pharmacological effects that could be of c l in ical 
intere t .  These effects include antiasthmatic action in  adu l ts and chi ldren ,  choleretic ,  uricosuric 
and anti- inflammatory effect, anti-bacterrial action, an immune system enhancer, uterine 
contraction stimulant and prothrombin t ime prolonging factor (El-Ridi .  et a I . ,  1 996) (Houghton et 
aL 1 995) .  Intere t ingly, N. stativa increased interleukin- l beta (Haq, 1 995) .  Its seed significantly 
reduce blood urea introgen and serum (El-Daly, 1 998) .  
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Figure 9. Nigella saliva 
a. Seeds 
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8) Salvia sclarea 
Engl i  h arne : Sage 
Local arne : J.....:...� 
De cr ipt i o n :  A mal l cult ivated hrub with a woody ba e 50-80 em high. Stem erect, 
herba eou with long oval , lanceolate, finely wrinkled grey- green leaves and violet flower 
arranged in a terminal spike ( Kotb 1 985) .  
Part used : The volati le oi l  and hade dried leave . 
Con t ituent : Volati le oi l  containing the fol lowing compounds, the terpene hydrocarbons alpha 
and beta pinene, myrcene and B-cymene, the sesquiterpenes caryophyl lene and alpha- humulene, 
the ox ide cineole, the ketone thujone and camphor and alcohol terpineole. The plant contains 
tann in  and the bitter principle picrosalvin (Kotb, 1 985) .  
U e : It  i u ed as flavouring agent in  food. In the form of infusion it is  used in cases of nervous 
di order , dizziness and trembling.  It stops prespiration, the action starts two hours after the dose 
i taken and prolongs for several days. The plant also has astrogenic properties ( Kotb, 1 985) it i s  
reported that i t  i used for hyperl ipidemia (Hassan ,2002) .  
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Figure l O . SaLv;a scfareC/. 
C/. Whole plant 
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uc1eo id and ucleo ide ynthe is 
The name nucleo ide i g iven to a hetero ide re ulted from the compination of : 
n 0 e (ribo e or 2- deo yribo e)  with purine or a pyrimidine base (aheterocycl ic tructure 
wI th  a ba ic haracter) joined by - glyco idic bond. 
Th purine and pyrimidine ba es 
1- Purine ba es 
Th term purine ini t ia l ly attributed to E. Fi cher to the heterocycl ic y tern fundamental to 
the uric ac id. 
The nucleu of purine 
The principal purine bases pre ent in each of the nucleic ac ids and the coenzymes are : 
a- Adenine ( 6-amino - purine ) 
b- Guanine ( 2- amino-6- hydroxy- purine ) 
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- Another n atural purine deri vative : 
1 .  Hydroxylated puri ne derivatives: 
- H poxanthene (6-hydroxy puri ne).  
- The anthene ( 2,6-di hydroxy purine). 
- The uric ac id (2 ,6,8-tri hydroxy purine).  
:ro H 
HN 6 N 
Jz 9=0 o N N 
H H 
Uric acid 
2- Puri ne derivat i ves methyl ated on the heterocycle or on its amino group. 
l l- Pyrimidine bases 
The three princ ipale pyrimidine bases are the cytosine,  the urac i l ,  and the thymine. 
N:) 0 0 HN� HNyC H3 
OJlN � O�N O�N H 
Cytosine Urac i l  Thymine 
o e of the nucleosides and nucleotides 
The oses involved in the structure of nucleosides, nucleotides and consequently in nucleic 
acid are pentoses : 
the D - ribose and the D - 2- deoxyribose : 
HO�rr 
HO O H  
f3 - D - R ibofuranose f3 - D - Deoxyribofuranose 
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The e are hetero ide which can be di  t i nguished to : 











b- The deoxyribonucleosides , which contain t he deoxyribose as t he ose part , e .g .  
o 




The ynthe i o f  nucleo i de are of very important , because the nucleo ide a wel l  a the 
nuele t ide are needed for di fferent purpo e , for example for their  biological act ivity a 
ant i v i ral , ant i tumor, . . .  etc . or for u ing a bui lding blocks for ol igonucleotides ynthesi of mal l 
fragment of DNA or RNA which are u eful in di fferent branches of biological tudies.  
The general methods for the synthe is of nuc1eosides 
1 .  B coupl ing of the chloromercuric salt of the ba e with the halogenosugar, for example :  
ACo-OC Br + 
OAc OAc 




B y  fusi ng together the heterocycl ic  base with the ful l y  acylated sugar in the presence of an 
ac id cataly t as in the synthesis of theophyl l i ne 7-/3 - ribofuranoside : 
3 .  Convert ing the base t o  the s i ly l  derivative with hexamethyld is i lazane, then react ion with the 
glycosyl hal ide in the presence of si lver perchlorate fol l owed by removal of the protecting 
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Stereochemi try and mechanism of nucleoside synthesis 
11 the early ynthesi of nucleosides yielded exclusively j3 - deri vatives. This was so, 
w hether the glyco yl hal i de had the u- or fJ - configuration or was a mixture. 
In the ca e of glyco yl  hal ides deri ved from ribose, the c is  (u) compound reacts by a simple 
S 2 reaction to give the fJ - nuc leoside product . 
B as e  
B ZOV�� )-(x) 
O B z O B z 
a 
B zo� as e 
O B z  O B z  
j3 
The trance fJ - g l ycosyl hal ide undergoes two SN2 reactions, the first being i ntramolecul ar 







B ase ( RCOO�Base 
"'-� � . $ 
RCOO 0-«:::0 RCOO OCOR 
R 
reactive e lectroph i l l ic sugar cation R= COCH3 
X= halogen 
It fol lows from this  t hat reactions with glycosyl hal ides which do not possess a 2-acyloxy 
group should l ack stereospeci ficity and give a mixture of a - and fJ - i somers . 
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R 0 0  
RCO O 















M��9) RCO O   R 
RCO O  
e 
+ SnC40Ac 
RCO O  
e 
+ OX 
+ C H3C02Si(CH3h 
b) (CH3)3SiS03CF3 
c) (CH3hS iC I04 
We would l i ke to explain the method of transglycosidylations with the example of 
tran fOffi1ation of pyrimidine nucleoside antibiotic 1 into the purine nucleoside � which is shown 




C H3 0 
N I 




nother example of transglycosylation technique is  the synthesis of 2' -deox fJ - L - 5 -
fluorouridine 2 (Lin et aI . ,  1 996), starting from 3' ,5'- dibenzoyl -2'-deoxy- f3 - L - uridine 1 as 










a - anomer f3 - anomer 
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lod i fied method for the synthesi of nucleosides 
Re ently Vorbrugen and co-worker howed that their one-pot nueleo ide ynthes i 
( orbruggen & Bennua 1 98 1  can be further implified by per i lylation of the free ugar free 
ba e fol lowed by conden ation in  the presence of Lewis acid (Bennua et aI . ,  1 995) .  Thu D­
nbo e and 6- azauraci l  with exces of hexamethyldis i lazane (HMDS)  and a catalytic amount of 
lrimelhy1chloro i lan (TCS) in  boi l ing acetonitri le for 1 -2 hours, gave through the presumed 
intermedIate 2 ( the 6- azauridine) (Chavi et al . 1 982) (Pudlo & Townsend, 1 992) in 68% yield. 
HO�� )--( O H  
OH O H  
1 
o HN)) 
o�w N I 
H 
2 
i) HMDSrrCS/CH3CN / 80 .. 




By doing the same react ion USing 6 - azauraci l  2 with glucose Q furnished the crude 
glycopyranoside 1 (65% yield  ) .  
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i) Me3SiOS02CF3/CH3CN/80 





Thi method gave also the arne results with N6- benzoyladenine 
OH 
o Me3SiOS02CF3 





La R= H 
b R= Ac 
OR 
Thi new s impl ified synthe is of free nucleosides wi l l  be of particular value in  those cases 
where the protected sugar derivatives are not commercial ly avai l able and only accessible by a 
mult i  tep synthe i s  as wel l  as when the free nucleosides haw to be prepared quickly. 
The use of stereospecific sodium salt glycosylation technique 
a- Synthesis of purine nucleoside : 
Over the years, 6-guanine nucleosides have been prepared and evaluated for their antitumer 
properties (Ishiguro et al . ,  1 984) (Saunders et al . ,  1 987) .  The most important of these are the a ­
and jJ - anomers of 2' - deoxy - 6 - thioguanosine II ( a  - and jJ - TGdR). 
By the use of the stereospecific sodium salt glycosylat ion technique (Cottam et al . ,  1 985) 
(Kazimierczuk et al . ,  1 990), Robins R.K. and co-workers (Hanna et aL , 1 988)synthesized 9- ( 2-
deoxy - fJ - D- ribofuranosyl ) purine - 6 - thione lQ as wel l as 2' - deoxy - 6 - thioguanosine II 
and ara - 6 - th ioguan i ne .lQ with a good yield as i l lustrated in the fol lowing scheme. 
Thus the sodium salt 1 (generated by the treatment with sodium hydride in acetoni tr i l ) was 
reacted with 1 - chloro - 2 - deoxy - 3,5 - di - 0 - p- toulyl - a - D - erythro - pentofuranose 1 at 
room temperature .  Two nucleoside products were formed : 6 - chloro - 9 - (2 - deoxy - 3,5 - di -
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- P - toluoyl - jJ - D - erythro - pentofuranosyl) purine 1: (6 1 % ) and the corre ponding - 7 
gJyco yJ i orner Q ( 1 3  % )  no formation of the a - anomer wa detcted. 
When 1: was treated with H2S in 1 M  MeONa in MeOH , deprotection of the carbohydrate 
moiety with nucleophi l ic  di placement of the 6-chJoro function to the 6- thio group occured to 
give 2' - deoxy - 6 - thioino ine lQ. A s imi lar gJycosylation of the sodium aJt of 2 - amino - 6 _ 
chI  ropurine � with the ugar derivative J , gave a mixture of 2 - amino - 6 - chloro - 9 - ( 2 -
deoxy - 3 ,5 - di - 0 - p - toluoyl - jJ - D - erthro - pentofuranosyl ) purine 2. (5 1 %) and the 
corre ponding N-7 gJyco yl i orner 1 in 9 % yield. 
gain ,  no formation of the a - anomers was detected . Subsequent treatment of 2. with H2S 
1 0  1 M MeO a in  MeOH readi ly provide ,8-TGdR 11 [2- amino - 9 - (2- deoxy- ,8- -erthro ­
pentofurano yl )  purine-6- thione ] in  7 1  % yield. Deprotection of 2. with rnethanol ic ammonia at 
room temperature gave 1 2  [2-amino-6-chloro-9- (2- deoxy-,8-D erthro - pentofuranosyl) purine i n  
68  % yield .  
Thi  general and tereospeci fc procedure has also been found to be equal ly appl icable to the 
preparat ion of the anti v iral (Kazimierczuk et al . ,  1 990) and antitumor (Saunders et al . ,  1 987) 
(Verhoef et a l . ,  1 986). Agent 9-,8- D- arabinofuranosyJguani ne (ara-G, 11 ). So Robins et al have 
reacted the odium salt of � wi th 1 - chloro -2,3,5- tri-O-benzyl-a-D-arabinofuranose � having 
nonpart ic ipat ing blocking groups in  anhydrous acetonitri l  (see the scheme) .  A c lean reaction was 
ob er ed and the two i omeric nucleosides 2-arnino-6-chloro-9-(2,3,S-tri -O-benzyl -,8-D­
arabinofuranosyl) purine 2 in 68 % yield and the corresponding N -7 posit ional isomer U in  
1 1  % yield were separated. No formation of the  a - anomers was detected. Debenzylation of  2 
gave 2- amino - 6 - ch loro - 9 - jJ - D - arabinofuranosyl purine 1 4  in  62% yield. 
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TOlOp C I  N � N 
To 10 
C I  �  � 
I TOlOl��l 
R 'NJ-� 
1· R= H 
�. R= NH2 
N aB • ')..-/ 
TolO 
1 R= H 6 1 %  
l R = NH 2 
To 10 
+ 
R N y=;CN 
To 10 
N � J N 
C I  
§ R= H 1 3% 
2 R =  NH 2 















.!Q R= H 
11 R =  NH 2 
1 2N N,OH 0 
HO 
HO 
1 7  (araG) 
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N H2--Z· ·J- � 
HOl��l 
N aSH ')..-/ 
HO 
Treatment of 11 v l th 2 aOH ga e araG (ll) In 7 1  % yIeld. ucleophihc dl placment of 
the 6-chl ro group of .2 w accomli  hed by the treatment with thiourea in boihng ethanol to 
afford U 1 11 5% yield . Treatment of 11 with odium hydro ulfide in boi l i ng ethanol ga e 2-
amin -9-fJ-D- arab 111 0 fur an 0 yl purine 6-thione lQ in 74% yield. 
Thus, lhl,' , Impl high - yield methodolgy provided a fac i le and convenient route to the 
large - cale preparat ion of biological ly ignificant purine nucleo ide , uch a 2' -
de yth loguano ine, ara-thioguanine and araG. 
b· "nth i of derivati e of pyrrolopyrimidine nucleosides 
anou arabinofurano yl nucleo ide , uch a ara - tubercidine 1 (Verhoef et aI . ,  1 986) and 
7-d aza-araG � ( eela & Winke ler, 1 982), they exhibit antiviral activity (Clercq, 1 987) .  Al 0 
ara - angivamcin 3a and 2'- deoxy - angivamycin 3b were found to be highly active again t 
orne D A and RNA viruse (Turk et a1 . ,  1 987) (Clercq et a I . ,  1 987) (Townsend et aI . ,  1 99 1 ) . 
HN� 
N H2�J-N) 
HO HO HO 
ara-tubercidin 1 7-deaza-araG 2 3a , R= H;  R'= OH 
( ara- sangivamycin) 
3b R=R'= H , 
(2'- deoxysangivamycin 
The ynthe is of the e antibiotics have been reported in low to moderate yield, employing 
a four tep oxidation- reduction procedure from their corre ponding f3 - D -ribonucleoside 
(Han ka et aI . ,  1 984). R .  K .  Robin and co-workers ( Kazimierczuk et aI . ,  1 990) (Rama amy et 
aI . ,  1 9  8 )  ynthe ized ara - toyocamycin 1 by the tereo pecific glycosylation of the odium sal t 
of readi ly aval l able 2 - ethoxyrnethyleneamino-5-bromopyrrole-3,4-dicarbon itrile 1. (Rama amy 
et aI . ,  1 986) with l -chloro-2,3,5-tri -O-benzyl -a-D-arabinofuranose � (Glaudeman & Fletcher, 
1 963), yielded of 2- ethoxymethyleneamino -5- bromo - 1 - (2,3 ,5-tri - 0 - benzyl -/3 - D -
arabinofurano yl)pyrrolo  - 3 ,4 - dicarbonitri l  Q , which was readily ring c losed on treatment with 
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methanol ic ammonia  to yield 4-amino -6-bromo -7- ( 2 ,3 ,5 - tri - ° - benzyl - fJ - D _ 
arabmofurano yl )  pyrrolo - [2 ,3-4] pyrimidine -5-carbon itri 7a . Reductive debromination of 7a 
wa accompli hed with B is(trimethyl i lyl )acetamide (BSA) in the presence of fluoride ion to give 
7b \ .. hich on ox idat ive hydrat ion by the treatment of NH40H / H202 fumi hed 4-arnino-7-(2 ,3 ,5-
tri -O-benzyl-,B-D- arabinofurano yl )  pyrrolo- [2 ,3-4] pyrimidine-5-carboxamide 8a which on 
deb nzylation gave 4-amino -7- fJ - D-arabinofuranosyl) pyrro!o - [2 ,3-4] pyrimidine -5 _ 
carb amide 8b . 
OEI 
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B "O�';J X 
Me O HIN H3• p + 
B no� 
B nO 
C l  
BnO 
B nO 
N H 2 0 
N�N H 2 l . . � . . ) 
HO��N 
'P 
H O  
11 a R =  Bn 
§ 79% 
b R= H ( ara- sangivamycin) 
B nO 
la X= Br 
b X= H 
Sangivamycine can be synthesized by the same technique using the 2 ,3 ,5-tri-O-benzyl - a ­
D - ribofuranosyl chloride instead of the sugar derivative as a sugar moiety. 
It is proved that thiosangivamycine (4- amino - 7 - fJ - D - ribofuranosyl pyrrolo [2.3-d] 
pyrimidine -5 - thiocarboxamide) has activi t ies against leukemia (Robins & Revankar, 1 985) .  
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Th olid - l iquid pha e - tran fer glycosylation technique 
F. ee la and co-worker (Seela et al . ,  1 988) de cribe the synthe is of 2'- deoxynucleo ide 
obtamed b the ol ide - l iquid pha e - tran fer glyco ylation technique (Seela et al . ,  1 987) (Seela 
at el . ,  1 992) and it tran formation to variou 4- ub t i tuted pyrro10 [2 ,3-d] pyrimidine 2' ,3' ­
dideoxyribofurano e .  So the glyco ylation of 4- chloropyrrolo [2,3-d] pyrimidine 1 with the 
halogeno e 2 in acetonitri l  with an exce s of powdered KOH and the cryptand Tris - [2-(2-
metho 'yetho y) ethy l ]  amine (TDA- l )  as a catalyst (Serafinowski, 1 990) . The reaction is 
omplete at room temperature within 1 5  minute to give 3 in 80 % yield no a - nucleoside is 
formed. GI co ylation under l iquid - l iquid condi tions (50% aqueou sodium hydroxide I 
dich loromethane) in the presence of tetrabutylammonium hydrogen sulfate gave only 63% yield 
( eela et al . ,  1 987) .  
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l\ I ATE RI A T  S AND l\ I ETH ODS 
Hormone and Chemi cal : 
Dulbecco' modified Eagle medium with low g lucose (DrvIEM) , Hank's balanced sal t solution 
(HB ) ,  calcJum-magne ium free HBS (C IF-HESS) ,  rvIEM amino acid solution l OX,  MEM non­
e ent ial aml llo aC id olut ion l OX and newborn calf erum ( lot# 4705) were purchased from GIBCO 
Laboratone:., Grand I land, Y. Penic i l l in- treptomycin-amphotercin  solut ion, bovine serum 
albumin (BSA,  A-7888),  Hoechst 33258,  and calf thymus DNA were purchased from S igma 
Chemlcal Company, S t . Louis ,  MO. The human tumor necrosis  factor-alpha (TNF-a) Enzyme l ink  
Immuno Sorbent  Assay (ELISA) ki t  were suppl ied by DIACLONE research ,  Besancon, France . 
. ' u c l  0 ide ynt hesis : 
ynthe 1 phta laz i none nuc leoside ( 1 -5 and 6) and cyanopyridone riboside (7) was 
a comp l t  hed by t he method of condensation of the syl i l ated base (phthalaz inone or 4,6-
dlmeth) 1- -cyano-2-pyridone) w i th  the peracylated sugar namely galactose, g lucose or ribose i n  
the pre ence o f  a Lewi  ac id (SnCI4) fol lowed b y  extract ion and chromatographic separation 
u mg l i t  a gel and fi nal ly  deprotect ion of the protected nucleosides by triethylamine.  
1 R = COCH3 
R = H  
R O  O R  
5 R = COCH3 








2 R = COCH3 
� R = H  
/ � CN 
H O  OH 
7 
Medicinal Plants :  
The plants were col lected from Al-Ain city i n  The United Arab Emirates. The leaves and 
Arial part were air dried in the shade, and then the dry leaves of the plant were powdered and used. 
The extract was prepared by adding 5g of powdered plant to 1 00 ml of distilled water for 1 6  h at 
room temperature with continuous shaking. Thereafter, the extract was fi l tered by sterile gauze 
followed by fi l ter paper (Wattman No 2) .  Plant polar extract was further fi l tered by Mi l l ipore nylon 
membrane fi l ter (0.22 11m). The tock olution was 5ml al iquots and kept frozen until used. The 
concentration of the dry material of the polar extract was the determined. 
Animals. The Wister rats used in the present study were original ly bought from Harlan Olae 
England) and raised in The Faculty of Medicine and Health Sciences local animal house faci l ity. 
Animals were housed in solid-bottom polypropylene cages containing heat-treated wood chips under 
condition of constant temperature (2 1 ± 1  C) and humidity (>60%) and maintained on 1 2-hour l ight­
dark cycle .  The standard laboratory chow and tap water were provided ad libitum. Male rats (250 
gm) were obtained on the day of the experiment .  
Preparation of Adipose Tissue Slices. Rats were narcotized with diethyl ether and immediately 
di sected under steri le conditions as possible. Subcutaneous adipose tissue was exposed at the 
shoulder area and ti sues were excised and placed in HBSS until transferred to the laminar flow 
hood. The adipose tissue was further dissected into 2 mm3 under sterile conditions. Tissue explants 
were p lated in 24 well -dishes using DMEM supplemented with newborn calf serum and antibiotic 
olution . 
Determination of Tumor Necrosis Factor-a. Rat TNF-a was measured in dupl icate using The 
Pel ikine human TNF-a ELISA kit. The kit is a "sandwich-type" of enzyme immunoassay in which a 
monoclonal anti -human TNF-a antibody is bound onto polystyrene microplate wel ls .  Rat TNF­
cx has about 85% cross reactivity with human TNF-cx. The val idity of TNF-a measurements in the 
rat has been conducted in DIACLONE research Laboratories, Besancon, France. They reported an 
85% cross reactivity with rat and mice TNF-cx. This kit was val idated for rat TNF-cx in culture media 
in our Laboratory (B iology Department, Faculty of Science). 
Rat TNF-cx present in a measured volume of sample is captured by the antibody on the 
microplate, and non-bound material is removed by washing. Subsequently, a b iotinylated polyclonal 
antibody is added to bind to the TNF-cx antibody complex present in the microplate wells .  Excess 
biotinylated antibody is removed by washing, fol lowed by addition of horseradish peroxidase (HRP) 
53 
conjugated treptavidin which bind onto the biotinylated side of the TNF-a sandwich. After 
removal of non-bound HRP conjugate by washing a ub trate solution is added to the wel l  . A 
colored product i formed in proportion to the amount of TNF-a present in the sample or tandard. 
fter the reaction has been terminated by the addition of a stop solution , absorbance is measured in a 
microplate plate reader. From the absorbance of samples and those of a standard curve, the 
concentrat ion of TNF-a can be determined by interpolation with the standard curve. The ELISA 
a had a lower detection l imit of 0 .5 pglml . The ELISA kit detects both free TNF-a and TNF-a 
bound to it oluble receptor. The intra-as ay coefficient of variation of TNF-a in media <8 .3%.  
Determination of Cellular DNA Content. Cell number was monitored using DNA qunati tative 
analy i . A c rude homogenate was made from adipose tissue for quantitation of DNA by a 
modification of the fluorescence method of Lab arc a and Paigen ( 1 980). 
At the end of each experiment, adipose tissues were washed three times with CMF-HBSS,  
re u pended in 1 ml of the same buffer and stored (-70°C) unti l assayed for DNA. Wells were 
further examined by microscopy to ensure complete recovery of tissue. Adipocyte cel l membranes 
were disrupted using a Branson Sonifier model 350 (Branson Sonic Power Company, Danburg, CT). 
onication was performed for 5 sec at 50% duty cycle and an output of 7 .  Then the samples were 
di luted 1 :  l O in Hoechst buffer. Fluorescence was read at 356 nm excitation and 458 emission using 
cal f thyrnu DNA as standard. 
Experimental Protocols. The exact protocol for each experiment is explained in the figure legend 
for each experiment. 
Statistical Analysis. Data were analyzed and differences among groups were conducted by two-way 
analysis of variance. Student's t test was used where appropriate to detect differences among 
individual means. The criterion for sign ificance was either P<0.05 or P<O.O l .  The re ults are 




The pre ent tudy was carried out  to screen the effect of several synthetic nucleo ides and 
orne commonly u ed medicinal plants on tumor necrosis factor alpha CTNF-a) secretion from 
adipo e ti ue in vi tro. In order to validate the screening sy tern, l ipopolysacharide (LPS), a 
potent timulator of TNF-a relea e from adipocytes, was found to stimulate TNF-a release in a 
do e dependent manner (Figure 1 1 ) .  Ro igl i tazone (RGZ), an inhibitor for TNF-a release from 
ad ipocyt , wa found to inhibit TNF-a release in al l  concentrations used (Figure 1 2) .  
Several medicinal plants have been commonly used in the United Arab Emirates for the 
treatment of diabetes as we l l  a other i l lnesses . In the present study, eight of these plants had 
been creened for their effect on tumor necrosis factor alpha (TNF-a) secretion from adipose 
ti ue in vi tro . The polar fractions of all plants were prepared using disti l led water as mentioned 
previou ly. 
The effect of Rhazya stricta (AI Hermel )  polar extract on TNF-a secretion from adipose 
ti ue in vitro was studied (Figure 1 3) .  At 90 and 1 20 /J.g/ml of media, Rhazya stricta polar 
extract inhibited ( P<O.OS) the TNF-a release (2 1 .9±2.2 vs. 1 3 .D±2.2 and 1 4 .3±2 .3  pgljJ.gDNA, 
re pecti ely). At lower concentrations (30 and 60 jJ.g/ml ,  the plant extract had no effect (P>O.OS ) 
on the release of TNF-a (2 1 .9±2.2  v . 1 8 .6±2 .S and 1 9 .4±3 . S  pgl/J.gDNA, respective ly) 
(Figure 1 4  ) domenstrates that the Salvia sclarea polar extract (30, 60 and 90 jJ.glml)  had 
al 0 inhibitory effect (P<O.OS) on TNF-a release from adipocytes in vi tro (S4.7±S . 8  vs. 40.3±4.6, 
27.9±2 . 8  and 1 7  .0±2.4 pgl/J.gDNA, respectively). Higher concentrations did not have any effect 
(P>O.OS) on TNF-a release from adipocytes. 
Nigella sativa polar extract (Figure I S) at 30 and 60 jJ.glml inhibited (P<O.OS) TNF­
a release from adipocytes in vi tro ( l 28 .9±7 .3  vs 64. S± I S .8  and S4.S± 1 3 .0 pg//J.gDNA, 
re pectively) . However, higher extract concentrations (90, 1 20, I SO jJ.g/mJ )  did not effect TNF­
a release ( l 28 .9±7 .3  vs 1 3S .4±2 1 .7, 9 1 . 8± 1 9.7 and 89.4± 1 9.7 pg//J.gDNA, respectively). 
Hammada elegans polar extract (Figure 1 6) did not have any effect on effect (P>O.OS) on 
TNF-a release from adipocytes .  Tumor necrosis factor released from control wel l s  was 
32.7±4 .2pg//jJ.g DNA. At al l concentration used (30,60,90, 1 20,and I SO /J.g/ml)  TNF-a release 
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Effect of Lipopolysachride on TNF-a release From Ad ipocyte In Vitro 
Control 1 0  20 50 80 
Li popolysacharide Concentration (/J.g/m l) 
1 00 
Figure 1 1 . Effect of Lipopo\ysachride (LPS) on TNF-a secretion from 
adipose tissue explant in vitro. Adipose tissue explants ( l mrn3) was plated in 
24 wel l-dishes in the presence or absence of test materials and kept in  the 
i ncubator for 48 h. The experiment was conducted in tripl icates. Each bar 
represents the average of 1 2  individual wel ls±S .D .  
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Effect of Rosig l itazone (RGZ) on TNF-a Release from Ad ipocytes I n  Vitro 
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Figu re 1 2 . Effect of  Rosig l itazone (RGZ) on TNF-a secretion from adipose 
t issue explants in vi tro . Adipose tissue explants ( l mm3) was p lated i n  24 wel l­
dishes in the presence or absence of test materials and kept in the i ncubator for 
48 h .  The experiment was conducted in  trip l icates. Each bar represents the 
average of 1 2  individual weUs±S.D. 



























Effect of Rhazya stricta Polar Extract on TNF-a Release From 
Adi pose Tissue Explant In Vitro 
Control 30 60 90 1 20 
Plant Extract Concentration ( Ilg/ml media) 
1 50 
Figu re 1 3. Effect of Rhazya stricta Polar extract on TNF-a Secret ion from 
Adipose Tissue Explant In Vitro Adipose ti ssue explants ( 1  rom3) was p lated in 
24 wel l -dishes i n  the presence or absence of test materials and kept i n  the 
i ncubator for 48 h .  The experiment was conducted in tripl icates. Each bar 
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Effect of Salvia sclarea Polar extract on TN F-a Release From 
Ad i pose Tissue Explant In Vitro 
Control 30 60 90 1 20 
Plant Extract Concentration (JlQ/ml media)  
1 50 
Figu re 1 4. Effect of Salvia sclarea Polar extract on TNF-a Secret ion from 
Adipose Tissue Explant In V itro Adipose t issue explants ( l rnrn3 ) was p lated i n  
24  wel l-dishes i n  the presence o r  absence of  test materials and kept in  the 
incubator for 48 h. The experiment was conducted in t rip l icates. Each bar 
represents the average of 1 2  i ndividual wel ls±S .D .  
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Effect of Nigel/a sativa Polar Extract on TNF-a Release From 
Adipose Tissue Explant In Vitro 
Control 30 60 90 1 20 
Plant Extract Concentration (�g/ml media)  
1 50 
Figu re 1 5. Effect Nigella sativa Polar extract on TNF-a Secretion from 
Adipose Tissue Explant In Vitro Adipose t issue explants ( 1  mmJ) \ as plated in  
24 wel l-dishes i n  the presence or absence of test materials and kept in  the 
i ncubator for 48 h. The experiment was conducted in t rip l icates. Each bar 
represents the average of 1 2  individual wellS±S.D .  
� >-" 




Effect of Hammada e/egans Polar Extract on TN F-a Release From 
Adipose Tissue Explant I n  Vitro 
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Figu re 1 6. Effect of Hammada elegans Polar extract on TNF-a ecretion 
from Adipose Tissue Explant In Vitro Adipose t issue explants ( I mm3) was 
plated in 24 wel l-dishes i n  the presence or absence of test materials and kept in  
the incubator for 48 h .  The experiment was conducted i n  trip l icates. Each bar 
represents the average of 1 2  i ndividual weUS±S.D.  
Anastatica hierochuntica polar extract (Figure 1 7) did not have any effect on effect 
(P>O 05) on TNF-a relea e from adipocytes .  However, high concentration ( 1 50 )lglml )  
mcrea ed  (P<0.05 ) TNF-a relea e (29.9±3.5 v 60.3±8 .4 pg/)lgDNA) 
Tephro ia apollinea polar extract (Figure 1 8) did not have any effect on effect (P>0.05) on 
T F-a relea e from adipocyte . However, high concentrat ion ( 1 50 )lg/ml) increased (P<0.05 ) 
T F-a re lease (40 .0±6. 8  vs 84.3±4 .4 pg/)lgDNA) 
Zygphyllum simplex polar extract (Figure 1 9) did not have any effect on effect (P>0.05) on 
T F-a re le e from adipocyte . However, high concentration ( 1 50 )lg/ml) increa ed (P<0.05) 
T F-a relea e (39 .8±6.4 vs 7 1 . 1 ±7 .5  pgl)lgDNA) 
Tell rium stocksianum polar extract (Figure 20) did not have any effect on effect (P>0.05 ) 
on T F-a release from adipocyte at low concentrations (30 and 60 )lg/ml) .  However, high 
concentration (90, 1 20 and 1 50 )lg/ml )  increased (P<0.05) TNF-a release (39.2±2 .3  vs 92.7±9.6, 
93 .7±9 ,4 and 93 .9±9.5  pg/)lgDNA) 
ynthetic phtalazinone nucleosides were either acetyl protected or left hydroxylated. (  
Figure 2 1 )  shows the effect of C2,3,4,6-tetra-O-acetyl-B-D-galactopyranosyl) phthalazinone 
(nucleo ide 1 )  which is synthetic phtal azinone galactoside with acetyl groups protection did not 
have any effect ( P>0.05) on TNF-a release from adipocytes at all concentrat ions used. However,  
at the h ighe t concentration (20 j.1g/ml media) , this nucleoside increased (P<0.05) TNF-a 
(92 . ±6.2  v . 1 77 .7± 1 8 .6  pg/)lg DNA). 
ucleoside m-D-galactopyranosyl)phthalazinone (nucleoside 2) i the deprotedcted 
phtalazinone galactoside (nucleoside 1 ), fol lowed the same pattern as (nucleoside 1 ) . Data i n  
(Figure 22) indicates that the (nucleoside 2) had no effect (P>0.05) on  TNF-a release from 
adipocyte at al l  concentrations used. However, at the highest concentrat ion (20 )lg/ml media), i t  
increased (P<0.05) TNF-a released from adipocytes (82.0± 1 4.8 vs .  1 7 1 . 1 ±22.9 pg/)lg DNA). 
ucleo ide C2,3,4,6-tetra-O-acetyl-B-D-glucopyranosyl) phthalazinone (nucleoside 3) was 
synthesized as phtalazinone glucoside with acetyl-protected groups. The (nucleoside 3) did not 
have (P>0.05) any effect on TNF-a release from adipocytes at al l  concentrations used (Figure 
23) .  
ucleoside m-D-glucopyranosyl)phthalazinone (nucleoside 4) is the deprotected form of 
phta]azinone glucoside (nuc leoside 3) .  The (nucleoside 4) did not have any effect (P>0.05) on 
T F-a release from adipocytes at both 2 and 5 )lglml media  (Figure 24) . Meanwhile, higher 
concentrations 1 0  and 20 )lg/ml media increased (P<0.05) TNF-a release (36.5±3 .5  vs. 70.7±7 .9  
and 53 .3±5.6 pgl)lg DNA,  respecti vely) .  
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Effect of Anastatica hierochuntica Polar Extract on TN F-a Re lease From 
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Fig u re 1 7. Effect of  Anastatica hierochuntica Polar extract on TNF-a. 
Secretion From Adipose Tissue Explant  In V itro Adipose tissue explants 
( l mm3)  was plated in 24 wel l-dishes in the presence or absence of test 
materials and kept i n  the i ncubator for 48 h. The experiment was conducted i n  
trip l icates. Each bar represents the average of 1 2  i ndividual weUs±S.D.  
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Effect of Tephrosia apollinea Polar extract on TNF-a Release From 
Ad ipose Tissue Explant In Vitro 
Control 30 60 90 1 20 
Plant Extract Concentration (J.1g/ml media) 
1 50 
Fig u re 1 8. Effect of Teplzrosia apollinea Polar extract on TNF-a Secretion 
From Adipose Tissue Explant In Vitro Adipose t issue explants ( l mmJ) was 
plated i n  24 wel l-dishes i n  the presence or absence of test materials and kept in  
the i ncubator for 48 h. The experiment was conducted i n  tripl icates. Each bar 
represents the average of 1 2  i ndividual wel ls±S .D .  
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Effect of Zygphyllum simp/ex Polar extract on TNF-(l Release From 
Ad ipose Tissue Explant In Vitro 
Control 30 60 90 1 20 
Plant Extract Concentration (Ilg/ml media) 
1 50 
Figure 1 9. Effect of Zygphyllum simplex Polar extract on TNF-a Secretion 
from Adipose Tissue Explant In Vitro Adipose tissue explants ( l mm3) was 
p lated in 24 wel l-dishes in the presence or absence of test materials and kept in 
the incubator for 48 h. The experiment was conducted in trip l icates. Each bar 




Effect of Teucrium stocksianum Polar Extract on TNF-a Release From 
Adipose Tissue Explant In Vitro 




























Control 30 60 90 1 20 
Plant Extract Concentration (�g/ml media) 
1 50 
Fig u re 20. Effect of Teucrium stocksianum Polar extract on TNF-a Secretion 
From Adipose Tissue Explant In Vitro Adipose t issue explants ( l mm3) was 
plated in 24 well -dishes in the presence or absence of test materials and kept in  
the i ncubator for 48 h .  The experiment was conducted i n  t rip l icates. Each bar 
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Effect of (2 ,3 ,4,6-tetra-O-acetyl-j3 -D-galactopyranosyl )phthalazinone 
on TNF-a Release From Adipose Tissue Explant In Vitro 
. . .  + . . .  . . . -l . . .  
Control C+ DMSO 2 5 1 0  
Nucleoside Concentration ( /lg/ml media) 
·······1· · ··· · ·· . . . . . . . . . . . .  . . . .  . . . . . . . . . . . .  . . . . 
I ! II ! I I : ! I 
I ! 
. . . . . . . . . · . . . . . . . . · . . . . . . . . · . . . . . . . . . . . . . . . . .  . . . . , . . .  . . . . . . .  . .  . . . . . . . . . .  . . . . . .  . . . . . . . .  . . . . . . . . . . . . . . . . . . . . .  . _ . .  , . . . . . 
20 
Figu re 2 1 .  Effect of C2,3,4,6-tetra-O-acetyl-B-D-galactopyranosyl) 
phthalazinone (nucleoside 1 )  on TNF-a secretion from adipose t issue exp lant 
in  v i tro. Adipose t issue explants ( l mrn3) was plated in 24 wel l-dishes in the 
presence or absence of test materials and kept in  the i ncubator for 48 h. The 
experiment was conducted in tripl icates . Each bar represents the average of 1 2  
indiv idual weJ1S±S.D.  
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Effect of (P -D-galactopyranosyl)phthalazi none 
on TNF-a. Release F rom Adi pose Tissue Explant In Vitro 
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Figu re 22 .  Effect of W-D-galactopyranosyl)phthalazinone (nucleoside 2) on 
TNF-a secretion from adipose t i ssue explant in v itro Adipose t issue exp]ants 
( l mm3) was plated in 24 wel l -dishes in the presence or absence of test 
materials and kept in the incubator for 48 h .  The experiment was conducted in 



















Effect of (2,3,4,6-tetra-O-acetyl-p-D-g lucopyranosyl)phtha lazinone 
on TNF-a Release From Adipose Tissue Explant In  Vitro 
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Figu re23. Effect of C2,3,4,6-tetra-O-acetyl-B-D-glucopyranosyl) 
phthalazinone (nucleoside 3) on TNF-a secretion from adipose t i ssue explant 
in v itro. Adipose tissue explants ( l mm3) was plated in 24 wel l -dishes in the 
presence or absence of test materials and kept in the incubator for 48 h. The 
experiment was conducted in t rip l icates. Each bar represents the average of 1 2  
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Effect of (J3-D-g lucopyranosyl)phthalazinone 
on TNF-a. Release From Adipose Tissue Explant In  Vitro 
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Figu re 24. Effect of CB-D-glucopyranosyl)phthalazinone (nuc leoside 4) on 
TNF-a. secretion from adipose t issue explant in  vi tro . Adipose t i ssue explants 
( l mm3) was plated in 24 wel l -dishes in the presence or absence of test 
materials and kept in the i ncubator for 48 h. The experiment was conducted in  
t rip l icates . Each bar represents the average of 1 2  individual wel ls±S.D.  
1 ucleo ide C2,3,S-tri-O-acetyl-p-D-ribofuranosyl)phthalazinone (nucleo ide S) , which i an 
a elylated form of phtalazinone riboside (P<O.OS) TNF-a relea ed from adipocytes at high 
concentration 5 1 0  and 20 �g/ml media (43 .4± l A  vs. 9 1 .8±9.8 ,  72.7±6.0 and 63 .7±6. 8  pg!�g 
D A, 
re pect ively) .  Low concentrat ion of this nucleoside did not have any effect (P>O.OS) on TNF-a 
relea e from adipocyte . (  Figure 2S) 
ucleoside (p-D-ribofuranosyl)phthalaz inone )(nucleoside 6), which is deprotected form of 
phta lazi none ribo ide (nucleoside S) ,  increased (P<O.OS) TNF-a released from adipocytes at both 
- and 1 0  )lg/ml media (63 .2± 1 1 .7 vs .  1 67A± 1 3 .9  and l S9 .8± 1 2 .3  pg/�g DNA, respectively) . 
However, at 2 �g/ml media, it did not have any effect (P>O.OS) on TNF-a release from 
adipocyte (63 .2± 1 1 .7 vs .  S3 . 3±7 .6 pg/�g DNA). In addition, 20 �g/ml media did not have any 
effect (P>O.OS) on TNF-a release from adipocytes (63 .2± 1 1 .7 vs. 86.9± 1 6.8 pg/)lg DNA) .  
(Figure 26) 
ucleoside (3-Cyano-4,6-dimethyl-2-pyridone riboside) (nucleoside 7) is a unique among 
a l l  other nucleosides, which is a riboside of 4,6-dimethyl-3-cyanopyridone. Al l  used 
concentrat ions i ncreased (P<O.OS) TNF-a released from adipocytes . Lower concentrations (2 
and S )lg/ml media) of (nuc leoside 7 )  caused greater increase in TNF-a released (S4.0±6.6 vs .  
1 86.8± 1 6.2 and 1 67 .0± 1 9. 3  pgl)lg DNA, respective ly) than higher concentrations (S4.0±6.6 vs .  
l 02.7± 1 8 .7  and 99.7± 1 6 .9  pg/)lg DNA, respectively). (Figure 27) 
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Control C+ DMSO 2 5 1 0  
Nucleoside Concentration (flg/ml media) 
· · · t· · · ·  . . . . . . . .  . . . .  . . . .  . . . . . . . .  . . .  . . .  . . . . . . . . .  . . . . . . . . .  . . . . . . . . .  . . . . . . . . .  . . . . . . . . .  . . . . . . . . .  . . . . . . . . .  . . . . . . . . .  . . . . . . . . .  . . . . . . . . .  . . . . . . . . .  . . . . . . . . .  . . . . . . . . .  . . . . . . . . .  . . . . . . . . .  . . . . . . . . .  . . . . . . . . .  . . . . . . . . .  . . . . . . . . .  . . . . . . . . .  . . . . . . . . .  . . . . . . . . .  
I 
20 
Fig u re 25. Effect of C2,3,5-tri-O-acetyl-p-D-ribofuranosy1)phthalaz inone 
(nucleoside 5) on TNF-a secretion from adipose t issue explant in v i tro 
Adipose t issue explants ( l mrn3) was plated in 24 wel l-dishes in the presence 
or absence of test materials and kept in the incubator for 48 h. The experiment 
was conducted in tripl icates. Each bar represents the average of 1 2  indiv idual 
wel ls±S .D. 
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Figure 26.  Effect of CB-D-ribofuranosyl)phthalazinone )(nucleoside 6) on 
TNF-a. secretion from adipose tissue explant in  v i tro Adipose t issue exp lants 
( l mm3) was p lated in 24 wel l -dishes in the p resence or absence of test 
materials and kept in the incubator for 48 h. The experiment w as conducted in 
tripl icates. Each bar represents the average of 1 2  indi idual wel l s±S .D .  
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Effect of 3-Cyano-4,6-d imethyl-2-pyridone riboside 
on TN F-a Release From Ad ipose Tissue Expla nt In  Vitro 
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Figu re 27.  Effect of (3-Cyano-4,6-dimetbyl-2-pyridone riboside) (nucleoside 
7) on TNF-a secretion from adipose t issue explant in v i tro Adipose t issue 
expiants ( l mrn3) w as plated in 24 wel l -dishes in the presence or absence of 
test materials and kept in  the incubator for 48 h .  The experiment was 
conducted i n  trip l icates . Each bar represents the average of 1 2  individual 
wel l s±S .D.  
Chapter four: 
D i  e ll I o n  
The pre ent tudy \ a carried out to  screen new synthetic nucleosides and 
commonJy u ed medicinal plant in the AE for their effect on tumor necrosis factor 
alpha (T, ;F-a) release from adipocytes in vitro. edicinal plants used in the present 
study \-\- ere elected according to thei:- potential effect on diabetes and/or obesity as 
reported by the Lnited Arab Emirates folk  medicin Rhazya stricla (Al Harmel) is a 
commonly. u ed plant in The United Arab Emirates folk medicin for the treatment of 
diabetes Lov, concentrations of the polar extract of Rhazya strlcta did not have any 
effect on T IF-a release from adipocytes. However, high concentrations i nhibited the 
relea e of Thr-a. ah'lO sclarea (Al Maramia) is a plant that is used for its desired 
tlavor as well as its anti -obesity effect . The polar extract for this plant was found to 
reduce T.\r-a release from adipocytes in vitro .  These forementioned plants showed 
potential effe t to reduce TNF-a from adipocytes. Further in vivo studies are 
mandatory to domenstrate whether or not they could reduce i nsul in resistance by 
el iminating this cytokine effect on insuline receptor. 
Another plant, i'hgella saliva (Black seed), that has been reported to be 
benificial for the treatment of various alaiments, was used in the present study. The 
polar extract of Nigella aliva was found to reduce TNF-a release from the adipocytes 
at low concentrat ions Higher concentrat ions did not have any effect on TNF-a. This 
could be explaind by the high concentration of potassium i n  the Nigella sativa extract. 
It is well documented that elevated potassium concentrat ions faci l itates the release of 
intracellular proteins through membrane depolarization coupled to an influx of 
caicium ions (Henquin. 1 978) 
The polar extract of Hammada elegans (Al Ramth)  arial parts did not have any 
effect on TNF-a releasde at all concentrations used. Hammada elegans plant i s  used 
as antimicrobial and also reported to reduce serum cholestro l .  Anastatica 
hierochuntica (Kef Mariam) is a plant that is commonJy used in The United Arab 
Emirates to faci l itate the expulsion of dead foetus and to ease uterine haemorrhage. 
Plant polar extract did not have any effect on TNF-a release from adipocytes at all 
concentrations used. At avery high concentration ( 1 50 ug/mJ), the extract increased 
7S 
the relea e of T'\r-a This could be explained by the fact that this high concentrat ion . � 
contain a high potasium oncentration that lead to depolarizat ion in  the cell membrane 
and the release of it intracel lular protein ( i . e. TNF-o.). The polar extract of 
Tephros/O apo//mea (al Dhafraa) followed the same pattern as the other plants. At 
high concentrat ions, the e 'tract induced a non- pecific release of TNF-o., and this 
ma\ be due to the high potas ium concentrat ions Zygphy//ul71 lmp//ex (AJ Herm) 
polar ext ract had no effect at all low concentrations used ; however, at high 
concent rat ion increased the T F-o. release. This increase may be due to the high 
pot a ium concentrat ions in the extract The Tellcrium stocksianul77 (Al Ja'adaa) is a 
medicinal plant the is widely u ed in the United Arab Emirates for the treatment of 
nau ea and vomit ing as el l as type I diabetes The plant extract increased TNF-o. 
release pro\·iding evidence that it could be used as ant i - inflamm atory or help the anti­
cancer chemotherapy 
The present study was carried out to screen new synthetic nucleosides for their 
eftect on tumor necrosis factor alpha (TNF-o.) release from adipocytes in vitro. 
1 Tucleosides and some of their metabolites trigger a variety of regulatory effects in 
biological systems (Concepci6 et  al . 1 998) .  They have been reported to be effiecient 
a anticancer, antiviral, and antibacterial agents (Dorman, 1 970; Robin, 1 986, 
Bourgeois and Seela, 1 99 I )  Synthetic nucleosides used in the present study were 
accomplished by the method of condensation of t he syli lated base (phthalazinone or 
4,6-dimethyl-3-cyanopyridone) with t he peraclated sugar (galactose, glucose or 
ribose) in the presence of Lewis acid (SnCI4) .  This was fol lowed by extract ion and 
chromatographic separation using silica gel and finally deprotection of the protected 
nucleosides by t ri ethylamine 
Galactosides that are acetylated (protected), (2,3 ,4,6-tet ra-O-acetyl-�-D­
galactop. ranosyl) phthalazinone, which i s  designated as nucleoside 1 and the 
deprotected form, W-D-galactopyranosyl)phthalazinone, which I S  designated 
nucleoside 2 had no effect on TNF-o. release at low concentrations. At the highest 
concentration used (20ug/ml), both nucleosides 1 and 2 exert a stimulatory effect on 
Th'F -a. release. These data are consistent with previously published reports (Dubey et 
al , 2002) Glucosides used in the present study were either protected such as (2,3 ,4,6-
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telra-O-acetyl-p-D-glucop.'rano yl)phthalazinone, which is designated nucleoside .3 
or deprotected uch as (p-D-glucopyranosyl )phthalazinone, which is designated as 
nucleo ide -+ Tucleoside .3 ,  acetyl protected, did not have any effect on TNF-a 
relea e from adipocy1e Thi was in agreement with the known phenomenon that 
acetyl protect ion retard nucleoside physiological act ion on cells . Meanwhi le, the 
deprotected nucleoside 4 increased TNF-a 
The riboside u ed in the present study \ ere either protected, (2,.3,5 -tri-O-acetyl­
p-D-ribofurano yl)phthalazinone, whic/l i s  designated nucleoside 5 or not protected, 
(p-D-ribofuranosy'1 )phthalazinone, which is  designated as nucleoside 6 Both 
ribosides increased TNF-a release from adipocytes .  These data are consistent with 
several published report s  that domenstrated that ribosides may have stimulatory effect 
on protein synthesis The cyanopyridone ribosides, 3 -Cyano-4,6-dimethyl-2-pyridone 
ribo Ide, v. hich de ignated as nucleoside 7, increased TNF-a release at all 
con entrations used. These results agree with published reports (Dubey et aI . ,  2002) .  
Obe i ty, a common multifactorial disorder, i s  a major risk factor for type 2 
diabetes, hypertension and coronary heart disease (Hager et al . ,  1 998) .  According to 
the definit ion of the World Health Organizat ion (WHO), approximately 6- 1 0% of the 
population in Westernized countries are considered obese. In  The United Arab 
Emirates, the prevalence of non-insul in  dependent diabetes (NlDDM) has been 
increasing in the last two decades and is approaching epidemic proport ions. NIDDM 
is accounted for 90�'o of diabetic individuals i n  The UAE. Obesity is often associated 
with hyperinsul inemia and insul in resistance (Stejskal et aI . ,  1 998) .  Type II diabetes 
is  characterized by insul in resi stance in skeletal muscle and insul in receptor 
dysfunct ion Obesity is  one of major  .c'ctor to induce insulin receptor dysfunction 
through the increase in  expression of tumor necrosis factor alpha (TNF-a) (Maegawa, 
2000) 
Fat cells p lay an important role in  insul in resistance through its endocrine 
functions such as production of leptin and TNF-a (smith et al . ,  1 999). I ida et al . 
( 1 998) reported that serum leptin correlates with body fat content rather than fasting 
plasma glucose, serum insul in and insul in sensitivity. In  addit ion they suggested that 
circulat i ng leptin per se is not the reason for hyperinsul inemia and insulin 
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in-en it ivlty I n  rat Ince fat t i  sue is a significant source of endogenous tumor 
necroSIS factor alpha (T if-a), it i uggested that TNF-a is  a mediator of the 
peripheral insulin resistance found in obesity ( TSlgO ef al. , 1999) .  
Tumour necrosis factor-alpha (TNF-a) i s  a pleiotropic cytokine i nvolved i n  
many metabolic responses i n  both normal and pathophysiological states. Recent 
tudies ugge t that T. -a may al 0 have a central role in obesity modulat ing energy 
expenditure, fat deposition and in ul in resistance (Bullo-Bonet et aL , 1 999). Tumor 
necro is factor alpha (TNF-a) mRNA expression has been reported to be up regulated 
in adipose tis ue from everal rodent model of obesity and diabetes (Rube et aI . ,  
1 999) This elevated expres ion has been assumed t o  b e  associated with the 
development of in ul in resi stance Tumor necrosis factor (TNF-a) is a key component 
in obesity - l inked in ulin resi tance because it inhibits insulin receptor signali ng and 
glucose transpoI1 in insul in-sensitive tissues (Lofgren et a! . ,  2000). Increased TNF-a 
content in fat contributes to insubn resistance by lowering insulin receptor protein 
tyrosine kinase activity while other insul in receptor characteristics ( insul in-binding 
capacity and affinity of insul in receptors to  the hormone) do not seem to be i nfluenced 
by this factor (Hrebicek et a! . ,  1 999) 
The chronic elevat ion of TNF-alpha in obesity may promote the development 
of the complex cardiovascular risk profi le (Samad et ai , 1 999), inhibits fat cell 
differentiation and may also mediate insulin resistance in adipocytes and the 
development of noninsulin-dependent diabetes mellitus (Hube and Hauner, 2000; and 
Qi and Pekala, 2000), may be an important specific and local factor in adipose t issue 
that influences the ability of insulin to stimulate glucose transport in human fat cells 
(Lofgren et aI , 2000), insulin resistance and the development of obesity and 
noninsulin-dependent diabetes mellitus and it may be involved in initiation of the 
autoimmune diabetes (Green and Flavell 1 999) 
In  conclusion, all nucleosides used had st imulatory effect on TNF-a release 
from adipocyte in vitro. This suggests a role for these nucleosides as anti-inflamatory 
agents and could also be used to enhance anti -cancer druges activity .  Sa/via sclarea 
(Al 1ararrua), Rhazya stricta (Al Rermel) and Nigella sativa (Black seed) could have 
potential to reduce TNF-a and thus improve insulin responsiveness in i nsulin 
sensitive t issues. Further in vivo studies are warranted to investigate these effects on 
type II d iabetes. 
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